Skip to main content
Open Research Africa logoLink to Open Research Africa
. 2025 Feb 7;6:22. Originally published 2023 Dec 14. [Version 2] doi: 10.12688/openresafrica.14406.2

Immunomodulatory effects of aflatoxin B1 (AFB1) and the use of natural products to ameliorate its immunotoxic effects: A review

Gilbert Kipkoech 1,a, Mercy Jepkorir 1, Sally Kamau 1, Alice Wanyoko 1, Susan Kibunja 1,2, Rechard Amozi Jeremiah 3, Johnson Masese 4, Vincent Ntui-Njock 5, Charles Mutai 4, Peter Mwitari 1
PMCID: PMC11885904  PMID: 40060373

Version Changes

Revised. Amendments from Version 1

Changes were made to the manuscript as per the comments provided by the reviewers. Among the changes made include writing in superscript all forms of mycotoxins (i.e. B 1 and not B1), removed the statement “recent findings” since year of publication was not considered during the review, and removing citations/references at the conclusion. We also removed the phrase “systematic review” as this was not the method used in this review. We considered the removal of trademark names (i.e. NovaSil Clay) and replaced it with a specific type of clay used in the trademarked product. In addition, we used the term “mold” instead of “fungus” as advised. We also addressed the comment that the hydroxylated metabolite AFM1 is excreted through the milk, and therefore this raises concern on the safety of young mammals and infants. In Figure 1, we added other types of fungi that produces aflatoxin B1. This is contrary to our first submission where we only mention A. flavus as the main producer of AFB1. As requested, we have mentioned in the manuscript that the effect of AFB1 on the production traits and lower body weight of farm animals is a consequence of the worse utilization of feed proteins. Lastly, we addressed a comment requesting restructuring of the subchapter “Use of natural products to alleviate immunotoxic effects of aflatoxin B1”. We changed this to “Natural Products: Binders and Metabolic Modulators Against Aflatoxin B 1 Immunotoxicity” to capture the specific intervention strategies (i.e. binders and metabolic modulators).

Abstract

Aflatoxin B 1 (AFB 1), a potent mycotoxin, is known to be an immunotoxic agent that causes various immune system disorders. It can cause immunosuppression by direct toxic effect on the host or by its ability to interfere with the immune response and thereby lead to secondary infections. The immunomodulatory effects of AFB 1 and its metabolites have been reported in many studies. Yet, the exact mechanisms responsible for these immunomodulatory effects are still obscure. This review summarizes the current findings on the interaction between AFB 1 and the host immune system, while also highlighting other potential mechanisms involved in AFB 1-induced immunosuppression. These potential mechanisms include modulation of cytokine production, production of inflammatory mediators and their receptors, activation of pro-inflammatory pathways, alteration in cell surface receptors involved in T cell activation and regulation of apoptosis. The review also discusses the findings on natural products that have been found capable of inhibiting AFB 1-induced immunosuppression in various animal models. With the latest exploration of natural products as a solution, the burden of aflatoxicosis in society is likely to subdue. Some of the promising natural products that have been highlighted to have ameliorative effects include grape seed proanthocyanidin extract (GSPE), bentonite clay, smectites clay and Spirulina plantesis among others. Considering the seriousness of aflatoxicosis in the public domain and lack of effective management approaches, there is an urgent need for more research to understand AFB 1-induced immunotoxicity and possible remedies.

Keywords: Aflatoxin B1, mycotoxin, immunotoxic, immunomodulatory, immunosuppression, natural products

Introduction

Aflatoxin is a secondary metabolite synthesized by a few particular types of mold 1 . The most common producing strains include Aspergillus flavus and Aspergillus parasiticus. These strains propagate on food crops such as maize, groundnuts and other oil-producing seeds 2 . Aflatoxin contamination of food is associated with acute illnesses that may result in death or hepatocellular carcinomas. According to statistics, more than 4 billion people globally are affected by aflatoxin contained in foods 3 . Today, more than 100 countries in the world have imposed aflatoxin regulations that are meant to safeguard animals and human health. Aflatoxins not only have caused health effects on animals and humans but also economic losses especially in countries that export maize and other susceptible food crops 4 . The major forms of aflatoxin that occur in various food types include B 1, B 2. G 1 and G 2. Of all these types, the predominant and most toxic form is aflatoxin B 1 2 .

The contribution of aflatoxin to pathogenesis of diseases such as liver cancer and immune suppression has been widely studied 5, 6 . Research findings have documented that aflatoxin B 1 is a hepatocacinogen in animal models 7 . Apart from carcinogenic 1 and other chronic toxicities, studies have also shown immunosuppressive effects. In a study by Qian et al. (2014) 8 , aflatoxin B 1 was shown to reduce the expression of interleukin 4 (IL-4) and upregulate the expression of proinflammatory cytokines inteferon-γ (INFγ) and tumor necrosis alpha (TNFα) in rats. Aflatoxin B 1 has been shown to suppress immunity by decreasing protective effects of vaccines 9 . Immunotoxic effects of aflatoxin B 1 are mainly felt by cell-mediated immunity, where it is able to decrease the levels of activated lymphocytes, suppress lymphoblastogenesis and impair delayed-type hypersensitivity 10 . In human subjects, aflatoxin B 1 is capable of changing immunological parameters in both cell-mediated and humoral immunity. High doses of aflatoxin B 1 have a greater impact on cellular immunity thereby resulting in decreased host resistance to pathogenic microbes 1113 . Studies have also shown the impact of AFB 1 ingestion on the levels of immunoglobulins. Ingestion of aflatoxin B 1 by birds leads to decreased levels of immunoglobulins IgM, IgA and IgG 14 .

Aflatoxin B 1 (AFB 1): Sources, occurrence, and exposure

Aflatoxin B 1 is mostly found in food products, like corn, cotton, peanuts and tree nuts. The presence of AFB 1 in these crops is influenced by several factors including temperature, humidity and insect damage 15 . Moreover, AFB 1 can also be present in animal feed since it can be produced by mold that grow on feed ingredients. The biosynthesis of aflatoxin B 1 is controlled by factors related to stress, like reactive oxygen species (ROS) and enzymes such as superoxide dismutase (SOD) and catalase (CAT) 16 . These oxidative stress elements play a role in both sclerotial differentiation (SD) as well as the production of aflatoxin B 1 in A. flavus. The peroxisomes and aflatoxisomes, which are organelles involved in responding to stress 16 , are responsible for the production of aflatoxins. The production process of AFB 1 is regulated by a combination of stress factors including lipid hydroperoxide, superoxide, hydroxyl radicals and thiyl radicals 16 . The link between stress and both SD and the biosynthesis of aflatoxin B 1 indicates that oxidative stress plays a role in the contamination of agricultural produces with AFB 1.

When it comes to exposure to AFB 1, it mainly occurs through consuming foods, especially cereal crops, such as corn and peanuts. AFB 1 has the potential to enter the food chain at various points such as before harvesting, after harvesting and during processing and storage 17 . When people consume food contaminated with AFB 1, the toxin can be absorbed into the body system and then spread to different organs in our body. The liver is particularly vulnerable to its effects 18 .

Methodology

A comprehensive literature review was carried out during the study. All the articles related to the topic were reviewed and evaluated. A thorough review and structured approach was used when selecting information from the credible sources. Scientific databases -Google Scholar, Scopus and PubMed -were used to obtain credible sources related to the study. To get these sources, search terms "Aflatoxin B 1," "immunomodulation," "immune system," "natural products," "phytochemicals," "immunotoxicity," were used. Age limit was not used to filter the articles. Publications were selected based on their relevance and scientific rigor. All the articles reporting on immunomodulatory effects of aflatoxin B 1 and or natural products with respect to immune function were selected. Conference abstracts, editorials, and opinion articles were excluded. The data collected from the articles are authors names, year of publication, journal details, name of natural products used to ameliorate immunotoxic effects of AFB 1 and main outcomes related to Aflatoxin B 1 immunomodulation and natural product interventions.

Immunotoxic mechanism of Aflatoxin B 1

AFB 1 has been shown to affect the immune systems at various levels. The mechanism of action of AFB 1 on the immune system is widespread and has not been clearly elucidated. From previous studies, aflatoxin B 1 or its activated metabolites exhibit an interaction with cellular proteins, including cytochrome enzymes 19, 20 . This kind of interaction impedes basic metabolism and synthesis of proteins. This eventually result in cell death 21 . Aflatoxins are hepatoxic and genotoxic in humans and susceptible animals. Upon consumption, aflatoxin is broken down in the liver by cytochrome P450 (CYP450) enzymes. Notably, CYP1A2 and CYP3A4 are responsible for metabolism of aflatoxins 22 . In the liver, aflatoxin is metabolized to active metabolite aflatoxin-8,9-epoxide which is a ROS. The production of ROS is exacerbated in the presence of AFB 1. A study by Ma et al. (2021) 23 showed that the intracellular levels of ROS increases significantly in the presence of AFB 1. The resulting ROS is capable of binding DNA, thus damaging it 22 . In addition, the active metabolites may bind to proteins, thus rendering them non-functional. According to Guengerich et al., (1998) 24 , CYP450 isoenzymes, CYP1A2 and CYP4A4, play a critical role in the metabolism of AFB 1 to generate a highly reactive compound, exo-8,9-epoxide. The formation of this highly reactive compound is an important step in the genotoxic pathway of aflatoxin. Exo-8,9-epoxide has the capacity to alter the conformation of DNA 25 and binds strongly to guanine bases in DNA to form aflatoxin-N7-guanine. According to Raney et al. (1993), the epoxide formed interferes with the role played by DNA-dependent RNA polymerase and consequently lead to a reduction in synthesis of RNA and proteins. The metabolism of aflatoxin into highly active metabolites may directly or indirectly interfere with proliferation and differentiation of immune cells and production of cytokines 26 . The immunotoxic mechanism of aflatoxin B 1 is shown in Figure 1.

Figure 1. Immunotoxic mechanism of aflatoxin B1.

Figure 1.

The metabolism of AFB 1 yields genotoxic metabolites, mainly 8,9-epoxide-AFB 1, which binds to DNA to form aflatoxin B 1-DNA adducts 24 . The adducts formed have the capacity to interfere with normal processes, including replication and transcription. This eventually leads to formation of DNA lesions in the dsDNA. If the exposure to AFB 1 is prolonged, more lesions are formed in the DNA and this will result in mutation and carcinogenesis 27 . Apart from the genotoxic effects of AFB 1, continuous exposure has been linked with severe consequences such as growth retardation, suppression of the immune system and teratogenic effects in human and farm animals. Yet, the exact mechanism of aflatoxin B 1 has not been fully understood 28 . Epigenetic modifications are inherited variations in how genes operate or expression of phenotype which have no impact on the nucleotide base pairings of the DNA strand 29 . Hepatocellular carcinoma may develop as a result of epigenetic changes brought about by AFB 1 exposure, including DNA methylation, non-coding RNA, and histone alteration, which may change the expression of certain genes right away or later.

Immunomodulatory effects of aflatoxin B 1

Effects on the components of innate immunity

Innate immunity is a first line of defense that consists of cells and mechanisms responsible for elimination of foreign antigens in the body 3032 . The major components of innate immunity are physical epithelial barriers, phagocytic leucocytes, complement system, dendritic cells and natural killer cells 33, 34 . The skin is a major organ that prevents entry of foreign particles into the body. There is evidence that AFB 1 has tumorigenic effects on the skin. For example, a study by Rastogi et al. (2006) 35 found that topical application of aflatoxin B 1 leads to the development of tumors. Aflatoxin B 1 can easily penetrate human skin and cause toxic effects. In animal models treated with aflatoxin B 1, some of the evident clinical symptoms included hair loss in the skin 36 . Epithelial cells are found in most soft tissues and form a physical barrier to most pathogens. Effects of aflatoxin in epithelial cells have been widely studied 37, 38 . AFB 1 and its hydroxylated metabolite, aflatoxin M 1 (AFM 1) have been reported to be cytotoxic to many cells including epithelial cells. The AFM 1 is excreted through the milk, and therefore it is important in aflatoxicosis in young mammals and infants. Wu et al. (2021) 37 in their study found that aflatoxin B 1 and its hydroxylated metabolite, AFM 1, causes inhibition of cell proliferation, apoptosis and arrests cell cycle. Wu et al. (2021) also noted that AFB 1 and AFM 1 brought about alteration of related gene expressions.

The intestinal innate system has also been shown to be adversely affected by dietary aflatoxin. Gastrointestinal mucosa form a barrier to ingested pathogens and there have been concerns over the damage caused by AFB 1. In their study, Gaikwad and Pillai (2004) 39 sought to study the effects ingested aflatoxin B 1 on the morphology and histochemical properties of the gastrointestinal tract (GIT) in mice. Their results indicated that there were significant changes in morphology and histochemical properties of GIT among the mice administered aflatoxin B1. AFB 1 was shown to severely damage the mucosal membranes and significantly decrease glycoprotein levels in the GIT. Gaikwad and Pillai concluded that aflatoxin B1 found in contaminated food may affect glycoprotein synthesis and affect the protection of GIT lining. Wang et al. (2018) 40 reported that histopathological injuries in GIT, structural changes and decreased expression of TLR particularly in the small intestines after AFB 1 exposures. Moreover, the histopathological observations indicated that the villi in the ileum of broiler chickens fed with AFB 1 were shedding. The goblet cells in the intestinal tract of broilers exposed to aflatoxin B 1 largely came down. At the molecular level, aflatoxin B 1 is capable of decreasing mRNA expression of toll-like receptors 2, 4 and 7 in the ileum 40 .

The immunomodulation effects of AFB 1 on human natural killer cells have been studied 41, 42 . Natural killer cells are component of innate immune system that plays a role of eliminating abnormal cells, including virally infected and tumorigenic cells 43 . It has been shown that aflatoxin B1 exhibits immunosuppressive effects on NK cell activity of healthy humans 44 . However, a study condcted by Sabourin et al. (2006) 45 found that splenic T-cells (CD4 + and CD8 +), B-cells (CD19 +) and NK cells (CD3 /NK1.1 +) levels remained unchanged after aflatoxin B 1 aerosol exposure of female mice as evaluated by flow cytometry analysis.

Phagocytosis is a fundamental process in innate immunity 46 . Phagocytic cells of innate immunity include neutrophils, macrophages, eosinophils and dendritic cells. According to Coulombe (1993) 47 , aflatoxins have a significant impact on various cell population in the thymus. For instance, their study found that the population of macrophages and their phagocytic activity was reduced under pathological state induced by AFB 1. Aflatoxins were also reported to reduce the activities of T-cell-dependent roles of mouse splenic lymphocytes. The role of phagocytic cells such as natural killer cells is depressed by aflatoxin B 1 44, 47 .

The innate immune system serves as the first line barrier against pathogenic attack, and it is notably important during invasion by bacteria or viruses in the mucosal membranes 48 . A number of studies has noted the effects of aflatoxins on different components of the innate immune system. Aflatoxins have been reported to impair the ability of cells of innate immunity to recognize foreign particles mainly by repressing the transcription of important receptors on the cell surface 40 . In their study, Wang et al. (2018) 40 reported that feeding the broilers with aflatoxin B 1 repressed the transcription of TLR-2, TLR-4 and TLR-7. This implies that aflatoxin B 1 suppresses the activity of innate immunity through the receptors involved in recognition of pathogenic microorganisms. It is also worth noting that the antigen-presenting activity of some phagocytic cells, for instance dendritic cells, is reduced as a result of aflatoxin B 1, although this reduction could not be linked to repression of toll-like receptors or specific cytokines 49 .

The complement system is an important arm of the innate immune system. This system is mainly responsible for activating phagocytosis of pathogenic microbes. Studies have shown that aflatoxins are responsible for inhibiting the complement pathways. Chen et al. (2014) 50 noted in their study that the classical and alternative complement pathway of Pekin Ducklings was impaired when fed with 0.11 to 0.21mg/kg of aflatoxin B 1. Valtchev et al. (2015) 51 also noted that low doses of AFB 1 for a shorter period had immune stimulatory effects on Moulard Ducks, whereas high dosage for extended period repressed the alternative pathway of complement system. At different dosages, cattle and poultry fed with AFB 1 had lower complement activity 51, 52 . In general, the activity of the complement system is suppressed by AFB 1.

Effects on the adaptive immune system

The adaptive immune system is a type of immunity responsible for fighting foreign materials that have overwhelmed the innate immune system 53 . The adaptive immune system is a system composed of T lymphocytes, B lymphocytes and antibodies 54 . The suppression of adaptive immunity after consumption of aflatoxin B1 is well documented in the literature and this implies an increased susceptibility to pathogenic infection, as well as compromised protection even after immunization 55 . A study by Tomková et al. (2002) demonstrated a remarkable reduction in the population of CD3 T cells in the mucosal membranes of the intestines of mice orally treated with aflatoxin B1. The decrease in the number of CD3 T cells implies a decrease in the host’s resistance to infectious pathogens. Similar effects have been documented in poultry through epidemiological studies associating AFB 1 ingestion to insufficient protection provided by immunization against Newcastle disease 51 . A similar study by Cysewski et al. (1978) 56 showed a failed protection of pigs fed with aflatoxin B 1 against Erysipelothrix rhusiopathiae infection after vaccination.

Studies on AFB 1 effects on T cells and expression of cytokines have been reported on animal models. Several studies have noted that exposure of AFB 1 in animal models has a remarkable immunosuppressive effect as well as impact on humoral and cellular responses 5, 57, 58 . Jiang et al. (2015a) 59 investigated the impact of aflatoxin B1 on the population of T-cell subclasses and the expression of cytokines in the small intestines of broilers. The population of T cells in the small intestines significantly decreased when compared to control group. Similarly, the expression of cytokines declined as compared to the control group.

The effect of AFB 1 on antibodies has been studied extensively 60, 61 . The study by Meissonnier et al. (2008) 62 showed that AFB 1 exposure does not elicit a significant impact on the levels of IgA, IgG and IgM antibodies in the serum of pigs. Jiang et al. (2015b) 63 noted that Cobb broilers fed with AFB 1 showed a significant reduction in the population of IgA (+) cells in the small intestine, duodenum and jejunum as compared to the untreated group. The mRNA expression levels of IgA, IgG and IgM in the lining of small intestines were significantly low in Cobb broilers fed with AFB 1. However, Benkerroum (2020) 64 noted that feeding the rats with 0.1 or 1mg AFB 1/kg b.w led to no change in anti-ovalbumin IgE and IgG antibody production in mesenteric lymph nodes even though it has profound impact on the proliferation of B and/or T cells. Similar findings have been documented by other researchers as well, especially a significant reduction in the levels of antibody after ingestion of AFB 1, although it is worth noting that the effect was not similar across all animal species used.

Effects of AFB 1 on immune organs

The impact of AFB 1 has been documented in a wide range of animal models. Peng et al. (2015) 65 conducted a study to investigate pathological changes in chicken immune organs upon ingesting AFB 1 and AFB 2. Histopathological examination showed that chickens fed with feeds contaminated with aflatoxins implicated nuclear debris in the thymus, bursa of Fabricius (BF) and spleen. A congestion of red pulp in the spleen was also observed, but not in the control group. The ultrastructure of the immune organs revealed abnormalities in the lymphocytes and reticulocytes of the thymus, BF, and spleen. It has also been demonstrated that ingestion of AFB 1 has an effect on the weight of the immune organs. Guo et al. (2012) 66 did a study to investigate the impacts of aflatoxin B1 on the immune organs of ducklings. In a group treated with 0.1 mg/kg b.w., BF, thymus indexes, and body weights were significantly lower in comparison to the untreated group. Long et al. (2016) 67 in their study found out that AFB 1 induces a reduction in body weight in mice, leading to a wasting away of immune organs. However, the ingestion of aflatoxin B 1-contaminated maize feed implicated greater relative weight of spleen and BF (He et al. (2013) 68 . Ingesting AFB 1-contaminated maize significantly affects the body weight, immune system, and relative immune organ weight in ducks 61, 68, 69 . It is therefore worth noting that the effect of AFB 1 on the production traits and lower body weight of farm animals is a consequence of the worse utilization of feed proteins.

Bioactive compounds and their mechanism of action

Plants possess a wide range of phytochemicals and most of them have their mechanism of action well elucidated. Some of the mechanism of actions that have been demonstrated include antimutagenic, antimicrobial, antioxidants, anticarcinogenic and anti-aflatoxic 7072 . Wu et al., (2017) 73 demonstrated that some plant antioxidants, through their scavenging of free radicals, are capable of protecting the integrity of the cell membrane and macromolecules such as DNA. Plant extracts have also been demonstrated to act through the induction of xenobiotic detoxification and biotransformation pathways 74 . Plant secondary metabolites such as polyphenols are able to inhibit the enzymes responsible for the activation of Phase I carcinogens 75 . They have also been demonstrated to induce enzymes that facilitate Phase II detoxification processes 76, 77 . The interference of enzymes in the two phases would affect metabolism of AFB 1 to active metabolites. Certain compounds such as fungal probiotics and ferments have been used as additives in food and animal feed to prevent the growth of mold and contamination by harmful substances called mycotoxins 78 . The use of these compounds have shown promise in controlling the risk of mutations and cancer caused by aflatoxins 79 .

Natural products: binders and metabolic modulators against Aflatoxin B 1 immunotoxicity

Using natural products for medicinal purposes has been a longstanding practice. There is increasing interest in substances that can help reduce the impact of aflatoxin B 1 on the immune system. Some studies have shown promising results in using these products to mitigate immunotoxic effects. For instance, a study conducted by Long et al. (2016) 67 discovered that grape seed proanthocyanidin extract (GSPE) can alleviate AFB 1 induced immunotoxicity in mice. The study found that mice exposed to AFB 1 experienced reduced organ weight and increased mortality compared to a control group. However, when administered with GSPE, the immune organ atrophy caused by AFB 1 was ameliorated. Gao et al. (2021) 80 in their study demonstrated that morin is capable of protecting the liver and the kidneys of chicks against damage caused by AFB 1.

Research has also been done to demonstrate the effects of binders such as bentonite clayin alleviating AFB 1-induced immunotoxicity. The study by Bhatti et al. (2017) 81 found that the administration of bentonite clay alongside feeds significantly reduced AFB 1-induced immunotoxicity in broilers. It was also observed that partial protection occurs at high AFB 1 doses of up to 0.6mg/kg body weight. Other binders such as calcium montmorillonite clay has also been studied and found to reduce aflatoxin B1 biomarkers in rats. This implies immunoprotective effects against AFB 1 (Mitchell et al. 2014) 82 . In a study by Afriyie-Gyawu et al. (2008) 83 involving human subjects, a natural clay binder of the smectite group was used in the management of aflatoxicosis. The results indicated that smectites clay is effective in protecting humans against aflatoxin-induced toxicities. Lai et al. (2021) 84 and Zhao et al. (2021) 85 conclusively noted that commercial mycotoxins-binder, XL, at a dose of 2g per kg body weight and other mycotoxin binders such as TOXO HP can ameliorate the immunotoxic effects of AFB 1 on broilers. Saleemi et al. (2020) 80 reported that local mycotoxin binder (LMB) can be used to combat the toxicopathological effects caused by AFB 1 in poultry. Their study demonstrated that the effectiveness of LMB in combating the undesirable consequences is dependent on LMB dose. Selenium has also been shown to protect against the toxic effects of aflatoxins (Chen et al. 2014; Liang et al. 2015; Singh et al. 2006) 8688 . Chand et al. (2011) 89 found out in their study that milk thistle at a dose of 10g/kg of feed can effectually be used as an immune-stimulant and in growth promotion in the presence of immunosuppressant AFB 1 in the feedstuff.

According to Singh et al. (2019), crude extracts of Premna integrifolia inhibits aflatoxin B 1 toxicity in mice. Aflatoxin B 1 induces toxicity in the liver which can be reversed by oral administration of Premna integrifolia. Singh et al. (2019) also demonstrated that crude extracts of Premna integrifolia restore hematological and serum parameters while also reducing the oxidative stress and hepatotoxicity caused by AFB 1 90 . Similarly, crude extracts of Annona senegalensis inhibit genotoxic effects resulting from AFB 1 in in vitro assays and this implies its role in cancer prevention 91 . In addition, in vitro studies involving crude extracts of Monanthotaxis caffra were shown to have inhibitory effect against AFB 1 genotoxicity 91, 92 . Pauletto et al. (2021) 93 demonstrated the ameriolative effects of resveratrol on AFB 1-induced toxicities. The findings of their study add to the understanding of important cellular processes associated with antioxidant-mediated defense against AFB 1 toxic effects. Consumption of food additives that modulate immune system have also been shown to be a promising approach in fight against aflatoxicosis 61, 69 . In a study by Kipkoech et al. (2023) 69 , crude extract of Spirulina plantesis could be used as an immune booster thus countering AFB 1 induced immune dysfunction and inflammation.

Future direction and conclusions

Aflatoxicosis is a worldwide problem. Research on the immunomodulation in AFB 1 toxicity has not been extensively done and there is a need to understand the mechanism of AFB 1-induced immunotoxicity. Aflatoxicosis is a serious, life-threatening problem caused by AFB 1 and other mycotoxins in the same family. It is one of the main causes of global deaths in people aged 20 years or older and about 25,200–155,000 annual hepatocellular carcinomas are directly linked to aflatoxin exposure 94 . There is an urgent need to develop safer feed additives that can be used in aflatoxicosis management. The use of novel approaches such as of bentonite clay, smectites clay, GSPE and other approaches highlighted in this paper would help solve this public health problem. Several other feed additives have shown promise, but still require further research for their use as immunomodulators.

A comprehensive literature review has pointed out that aflatoxin B 1 is the most potent mycotoxin. The health implication of ingesting this toxin is a serious public health concern. The existing approaches that can be used to manage aflatoxicosis are not very effective, which calls for more research to understand the exact mechanism of AFB 1 immunotoxity and develop effective control measures. Aflatoxicosis not only affects humans but also domestic animals. The consumption of animal products from animals that have consumed AFB 1-contaminated feeds worsens the situation. As advancements in research are ongoing to develop effective interventions, the ultimate approach that can be used to reduce aflatoxin exposure is through proper management of cereals from harvesting to storage. Studies have noted that proper drying and storage of cereals prevents Aspergillus flavus growth and toxin production.

Funding Statement

The author(s) declared that no grants were involved in supporting this work.

[version 2; peer review: 1 approved, 2 approved with reservations]

Data availability

No data are associated with this article.

References

  • 1. Mohsenzadeh MS, Hedayati N, Riahi-Zanjani B, et al. : Immunosuppression following dietary aflatoxin B 1 exposure: a review of the existing evidence. Toxin Rev. 2016;35(3–4):121–127. 10.1080/15569543.2016.1209523 [DOI] [Google Scholar]
  • 2. Gourama H, Bullerman LB: Aspergillus flavus and aspergillus parasiticus: aflatoxigenic fungi of concern in foods and feeds: a review. J Food Prot. 1995;58(12):1395–1404. 10.4315/0362-028X-58.12.1395 [DOI] [PubMed] [Google Scholar]
  • 3. Williams JH, Phillips TD, Jolly PE, et al. : Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr. 2004;80(5):1106–1122. 10.1093/ajcn/80.5.1106 [DOI] [PubMed] [Google Scholar]
  • 4. Wu F, Guclu H: Aflatoxin regulations in a network of global maize trade. PLoS One. 2012;7(9): e45151. 10.1371/journal.pone.0045151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Saha Turna N, Comstock SS, Gangur V, et al. : Effects of aflatoxin on the immune system: evidence from human and mammalian animal research. Crit Rev Food Sci Nutr. 2024;64(27):9955–9973. 10.1080/10408398.2023.2219336 [DOI] [PubMed] [Google Scholar]
  • 6. Zhu Q, Ma Y, Liang J, et al. : AHR mediates the aflatoxin B 1 toxicity associated with hepatocellular carcinoma. Signal Transduct Target Ther. 2021;6(1): 299. 10.1038/s41392-021-00713-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. McLean M, Dutton MF: Cellular interactions and metabolism of aflatoxin: an update. Pharmacol Ther. 1995;65(2):163–192. 10.1016/0163-7258(94)00054-7 [DOI] [PubMed] [Google Scholar]
  • 8. Qian G, Tang L, Guo X, et al. : Aflatoxin B 1 modulates the expression of phenotypic markers and cytokines by splenic lymphocytes of male F344 rats. J Appl Toxicol. 2014;34(3):241–249. 10.1002/jat.2866 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Venturini MC, Perfumo CJ, Risso MA, et al. : Effect of aflatoxin B 1 on resistance induced by Bordetella bronchiseptica vaccine in rabbits. Vet Microbiol. 1990;25(2–3):209–216. 10.1016/0378-1135(90)90078-a [DOI] [PubMed] [Google Scholar]
  • 10. Meissonnier GM, Marin DE, Galtier P, et al. : Modulation of the immune response by a group of fungal food contaminant, the aflatoxins. Nutrition and immunity. 2006;147–166. Reference Source [Google Scholar]
  • 11. Jiang Y, Jolly PE, Ellis WO, et al. : Aflatoxin B 1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol. 2005;17(6):807–814. 10.1093/intimm/dxh262 [DOI] [PubMed] [Google Scholar]
  • 12. Jiang Y, Jolly PE, Preko P, et al. : Aflatoxin-related immune dysfunction in health and in human immunodeficiency virus disease. Clin Dev Immunol. 2008;2008: 790309. 10.1155/2008/790309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Sahoo PK, Chattopadhyay SK, Sikdar A: Immunosuppressive effects of induced Aflatoxicosis in rabbits. J Appl Anim Ethics Res. 1996;9(1):17–26. 10.1080/09712119.1996.9706100 [DOI] [Google Scholar]
  • 14. Agag BI: Mycotoxins in foods and feeds: aflatoxins. Association of Universal Bullettin of Environmental Research. 2004;7(1):173–191. [Google Scholar]
  • 15. Bosch G, van der Fels-Klerx HJ, de Rijk TC, et al. : Aflatoxin b1 tolerance and accumulation in black soldier fly larvae ( Hermetia illucens) and yellow mealworms ( Tenebrio molitor). Toxins (Basel). 2017;9(6): 185. 10.3390/toxins9060185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Grintzalis K, Vernardis SI, Klapa MI, et al. : Role of oxidative stress in sclerotial differentiation and aflatoxin B 1 biosynthesis in Aspergillus flavus. Appl Environ Microbiol. 2014;80(18):5561–5571. 10.1128/AEM.01282-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Peivasteh-Roudsari L, Pirhadi M, Shahbazi R, et al. : Mycotoxins: impact on health and strategies for prevention and detoxification in the food chain. Food Rev Int. 2022;38(sup1):193–224. 10.1080/87559129.2020.1858858 [DOI] [Google Scholar]
  • 18. Zhang L, Ye Y, An Y, et al. : Systems responses of rats to aflatoxin B 1 exposure revealed with metabonomic changes in multiple biological matrices. J Proteome Res. 2011;10(2):614–623. 10.1021/pr100792q [DOI] [PubMed] [Google Scholar]
  • 19. Antonius Y, Kharisma VD, Widyananda MH, et al. : Prediction of aflatoxin-B 1 (AFB 1) molecular mechanism network and interaction to oncoproteins growth factor in hepatocellular carcinoma. J Pure Appl Microbiol. 2022;16(3):1844–1854. 10.22207/JPAM.16.3.29 [DOI] [Google Scholar]
  • 20. Khan MT, Irfan M, Ahsan H, et al. : CYP1A2, 2A13, and 3A4 network and interaction with aflatoxin B 1. World Mycotoxin J. 2021;14(2):179–189. 10.3920/WMJ2020.2621 [DOI] [Google Scholar]
  • 21. Haschek WM, Rousseaux CG, Wallig MA, et al. : Haschek and Rousseaux's handbook of toxicologic pathology.Academic Press,2013. Reference Source [Google Scholar]
  • 22. Wild CP, Montesano R: A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. Cancer Lett. 2009;286(1):22–28. 10.1016/j.canlet.2009.02.053 [DOI] [PubMed] [Google Scholar]
  • 23. Ma J, Liu Y, Guo Y, et al. : Transcriptional profiling of aflatoxin B 1-induced oxidative stress and inflammatory response in macrophages. Toxins (Basel). 2021;13(6):401. 10.3390/toxins13060401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Guengerich FP, Johnson WW, Shimada T, et al. : Activation and detoxication of aflatoxin B 1. Mutat Res. 1998;402(1–2):121–128. 10.1016/s0027-5107(97)00289-3 [DOI] [PubMed] [Google Scholar]
  • 25. Raney VM, Harris TM, Stone MP: DNA conformation mediates aflatoxin B 1-DNA binding and the formation of guanine N7 adducts by aflatoxin B 1 8, 9-exo-epoxide. Chem Res Toxicol. 1993;6(1):64–68. 10.1021/tx00031a010 [DOI] [PubMed] [Google Scholar]
  • 26. Dugyala RR, Sharma RP: The effect of aflatoxin B 1 on cytokine mRNA and corresponding protein levels in peritoneal macrophages and splenic lymphocytes. Int J Immunopharmacol. 1996;18(10):599–608. 10.1016/s0192-0561(96)00066-5 [DOI] [PubMed] [Google Scholar]
  • 27. Wang JS, Groopman JD: DNA damage by mycotoxins. Mutat Res. 1999;424(1–2):167–181. 10.1016/s0027-5107(99)00017-2 [DOI] [PubMed] [Google Scholar]
  • 28. Feng WH, Xue KS, Tang L, et al. : Aflatoxin B 1-induced developmental and DNA damage in Caenorhabditis elegans. Toxins (Basel). 2016;9(1): 9. 10.3390/toxins9010009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Ferreira RG, Cardoso MV, de Souza Furtado KM, et al. : Epigenetic alterations caused by aflatoxin B 1: a public health risk in the induction of hepatocellular carcinoma. Transl Res. 2019;204:51–71. 10.1016/j.trsl.2018.09.001 [DOI] [PubMed] [Google Scholar]
  • 30. Bernsmeier C, van Der Merwe S, Périanin A: Innate immune cells in cirrhosis. J Hepatol. 2020;73(1):186–201. 10.1016/j.jhep.2020.03.027 [DOI] [PubMed] [Google Scholar]
  • 31. Rafei H, Daher M, Rezvani K: Chimeric Antigen Receptor (CAR) Natural Killer (NK)‐cell therapy: leveraging the power of innate immunity. Br J Haematol. 2021;193(2):216–230. 10.1111/bjh.17186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Diamond MS, Kanneganti TD: Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23(2):165–176. 10.1038/s41590-021-01091-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Rodrigues LP, Teixeira VR, Alencar-Silva T, et al. : Hallmarks of aging and immunosenescence: connecting the dots. Cytokine Growth Factor Rev. 2021;59:9–21. 10.1016/j.cytogfr.2021.01.006 [DOI] [PubMed] [Google Scholar]
  • 34. Mukherjee J, Das PK, Banerjee D, et al. : Immune system.In: Textbook of Veterinary Physiology.Singapore: Springer Nature Singapore,2023;89–110. 10.1007/978-981-19-9410-4_5 [DOI] [Google Scholar]
  • 35. Rastogi S, Dogra RKS, Khanna SK, et al. : Skin tumorigenic potential of aflatoxin B 1 in mice. Food Chem Toxicol. 2006;44(5):670–677. 10.1016/j.fct.2005.09.008 [DOI] [PubMed] [Google Scholar]
  • 36. Murad AF, Ahmed S, Abead S: Toxicity effect of aflatoxin B 1 on reproductive system of albino male rats. Pak J Biol Sci. 2015;18(3):107–114. 10.3923/pjbs.2015.107.114 [DOI] [Google Scholar]
  • 37. Wu K, Jia S, Zhang J, et al. : Transcriptomics and flow cytometry reveals the cytotoxicity of aflatoxin B 1 and aflatoxin M 1 in bovine mammary epithelial cells. Ecotoxicol Environ Saf. 2021;209: 111823. 10.1016/j.ecoenv.2020.111823 [DOI] [PubMed] [Google Scholar]
  • 38. Mo YX, Ruan ML, Wang J, et al. : Mitigating the adverse effects of Aflatoxin B 1 in LMH, IPEC-J2 and 3D4/21 cells by a novel integrated agent. Food Chem Toxicol. 2023;178: 113907. 10.1016/j.fct.2023.113907 [DOI] [PubMed] [Google Scholar]
  • 39. Gaikwad SS, Pillai MM: Effect of aflatoxin B sub (1) in gastrointestine of mice. Journal of Ecophysiology and Occupational Health. 2004;4(3):153–159. Reference Source [Google Scholar]
  • 40. Wang F, Zuo Z, Chen K, et al. : Histopathological injuries, ultrastructural changes, and depressed tlr expression in the small intestine of broiler chickens with aflatoxin B 1. Toxins (Basel). 2018;10(4): 131. 10.3390/toxins10040131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. AL-Kelabi HF, AL-Obaidi AB: A study of the presence of Aflatoxin B1 on patients with liver disease and effect some immunological parameters. Ann Rom Soc Cell Biol. 2021;25(4):16888–16899. Reference Source [Google Scholar]
  • 42. Chao H, Ma H, Sun J, et al. : Whole-transcriptome analysis of non-coding RNA alteration in porcine alveolar macrophage exposed to aflatoxin B 1. Toxins (Basel). 2022;14(6):373. 10.3390/toxins14060373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Topham NJ, Hewitt EW: Natural killer cell cytotoxicity: how do they pull the trigger? Immunology. 2009;128(1):7–15. 10.1111/j.1365-2567.2009.03123.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Methenitou G, Maravelias C, Athanaselis S, et al. : Immunomodulative effects of aflatoxins and selenium on human natural killer cells. Vet Hum Toxicol. 2001;43(4):232–234. [PubMed] [Google Scholar]
  • 45. Sabourin PJ, Price JA, Casbohm SL, et al. : Evaluation of acute immunotoxicity of aerosolized aflatoxin B 1 in female C57BL/6N mice. J Immunotoxicol. 2006;3(1):11–20. 10.1080/15476910500468635 [DOI] [PubMed] [Google Scholar]
  • 46. Rosales C, Uribe-Querol E: Phagocytosis: a fundamental process in immunity. Biomed Res Int. 2017;2017: 9042851. 10.1155/2017/9042851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Coulombe RA, Jr: Nonhepatic disposition and effects of aflatoxin B 1. The toxicology of aflatoxins: human health, veterinary and agricultural significance. 1993;89–101. [Google Scholar]
  • 48. Levy JA: The importance of the innate immune system in controlling HIV infection and disease. Trends Immunol. 2001;22(6):312–316. 10.1016/s1471-4906(01)01925-1 [DOI] [PubMed] [Google Scholar]
  • 49. Mehrzad J, Devriendt B, Baert K, et al. : Aflatoxin B 1 interferes with the antigen-presenting capacity of porcine dendritic cells. Toxicol In Vitro. 2014;28(4):531–537. 10.1016/j.tiv.2013.11.015 [DOI] [PubMed] [Google Scholar]
  • 50. Chen X, Horn N, Cotter PF, et al. : Growth, serum biochemistry, complement activity, and liver gene expression responses of Pekin ducklings to graded levels of cultured aflatoxin B 1. Poult Sci. 2014;93(8):2028–2036. 10.3382/ps.2014-03904 [DOI] [PubMed] [Google Scholar]
  • 51. Yunus AW, Razzazi-Fazeli E, Bohm J: Aflatoxin B 1 in affecting broiler’s performance, immunity, and gastrointestinal tract: a review of history and contemporary issues. Toxins (Basel). 2011;3(6):566–590. 10.3390/toxins3060566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Stewart RG, Skeeles JK, Wyatt RD, et al. : The effect of aflatoxin on complement activity in broiler chickens. Poult Sci. 1985;64(4):616–619. 10.3382/ps.0640616 [DOI] [PubMed] [Google Scholar]
  • 53. InformedHealth.org.Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); The innate and adaptive immune systems.2006; [Updated 2020 Jul 30]. Reference Source
  • 54. Crotty S: Hybrid immunity. Science. 2021;372(6549):1392–1393. 10.1126/science.abj2258 [DOI] [Google Scholar]
  • 55. Monson MS, Settlage RE, Mendoza KM, et al. : Modulation of the spleen transcriptome in domestic turkey ( Meleagris gallopavo) in response to aflatoxin B 1 and probiotics. Immunogenetics. 2015;67(3):163–178. 10.1007/s00251-014-0825-y [DOI] [PubMed] [Google Scholar]
  • 56. Cysewski SJ, Wood RL, Pier AC, et al. : Effects of aflatoxin on the development of acquired immunity to swine erysipelas. Am J Vet Res. 1978;39(3):445–448. [PubMed] [Google Scholar]
  • 57. Elwan H, Mohamed ASA, Dawood DH, et al. : Modulatory effects of Arctostaphylos uva-urs extract in ovo injected into broiler embryos contaminated by aflatoxin B 1. Animals (Basel). 2022;12(16): 2042. 10.3390/ani12162042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Yilmaz S, Bağ H: Aflatoxin B 1: mechanism, oxidative stress and effects on animal health. J Anim Biol Vet. 2022;2:1–16. Reference Source [Google Scholar]
  • 59. Jiang M, Peng X, Fang J, et al. : Effects of aflatoxin B 1 on T-cell subsets and mRNA expression of cytokines in the intestine of broilers. Int J Mol Sci. 2015;16(4):6945–6959. 10.3390/ijms16046945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Wan F, Tang L, Rao G, et al. : Curcumin activates the Nrf2 Pathway to alleviate AFB 1-induced immunosuppression in the spleen of ducklings. Toxicon. 2022;209:18–27. 10.1016/j.toxicon.2022.01.010 [DOI] [PubMed] [Google Scholar]
  • 61. Masese J, Kipkoech G, Kimoloi S, et al. : Protective effect of Spirulina platensis extract on aflatoxin B 1 immunotoxicities in mice. The Journal of Phytopharmacology. 2023;12(1):27–31. 10.31254/phyto.2023.12104 [DOI] [Google Scholar]
  • 62. Meissonnier GM, Pinton P, Laffitte J, et al. : Immunotoxicity of aflatoxin B 1: impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression. Toxicol Appl Pharmacol. 2008;231(2):142–149. 10.1016/j.taap.2008.04.004 [DOI] [PubMed] [Google Scholar]
  • 63. Jiang M, Fang J, Peng X, et al. : Effect of aflatoxin B 1 on IgA + cell number and immunoglobulin mRNA expression in the intestine of broilers. Immunopharmacol Immunotoxicol. 2015;37(5):450–457. 10.3109/08923973.2015.1081933 [DOI] [PubMed] [Google Scholar]
  • 64. Benkerroum N: Chronic and acute toxicities of aflatoxins: mechanisms of action. Int J Environ Res Public Health. 2020;17(2):423. 10.3390/ijerph17020423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Peng X, Bai S, Ding X, et al. : Pathological changes in the immune organs of broiler chickens fed on corn naturally contaminated with aflatoxins B 1 and B 2. Avian Pathol. 2015;44(3):192–199. 10.1080/03079457.2015.1023179 [DOI] [PubMed] [Google Scholar]
  • 66. Guo S, Shi D, Liao S, et al. : Influence of selenium on body weights and immune organ indexes in ducklings intoxicated with aflatoxin B 1. Biol Trace Elem Res. 2012;146(2):167–170. 10.1007/s12011-011-9246-z [DOI] [PubMed] [Google Scholar]
  • 67. Long M, Zhang Y, Li P, et al. : Intervention of Grape Seed Proanthocyanidin Extract on the subchronic immune injury in mice induced by aflatoxin B 1. Int J Mol Sci. 2016;17(4):516. 10.3390/ijms17040516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. He J, Zhang KY, Chen DW, et al. : Effects of vitamin E and selenium yeast on growth performance and immune function in ducks fed maize naturally contaminated with aflatoxin B 1. Livest Sci. 2013;152(2–3):200–207. 10.1016/j.livsci.2012.12.018 [DOI] [Google Scholar]
  • 69. Kipkoech G, Musembi S, Masese J, et al. : Evaluation of effects of spirulina extracts on immunologic dysfunction and inflammation associated with Aflatoxin B 1 induced toxicity in mice. Journal of Scientific and Innovative Research. 2023;12(1):1–7. 10.31254/jsir.2023.12101 [DOI] [Google Scholar]
  • 70. Malik S, Kaur K, Prasad S, et al. : A perspective review on medicinal plant resources for their antimutagenic potentials. Environ Sci Pollut Res Int. 2022;29(41):62014–62029. 10.1007/s11356-021-16057-w [DOI] [PubMed] [Google Scholar]
  • 71. de Carvalho APA, Conte-Junior CA: Health benefits of phytochemicals from Brazilian native foods and plants: antioxidant, antimicrobial, anti-cancer, and risk factors of metabolic/endocrine disorders control. Trends Food Sci Technol. 2021;111:534–548. 10.1016/j.tifs.2021.03.006 [DOI] [Google Scholar]
  • 72. Umaya SR, Vijayalakshmi YC, Sejian V: Exploration of plant products and phytochemicals against aflatoxin toxicity in broiler chicken production: present status. Toxicon. 2021;200:55–68. 10.1016/j.toxicon.2021.06.017 [DOI] [PubMed] [Google Scholar]
  • 73. Wu Q, Wang X, Nepovimova E, et al. : Antioxidant agents against trichothecenes: new hints for oxidative stress treatment. Oncotarget. 2017;8(66):110708–110726. 10.18632/oncotarget.22800 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Kurade MB, Ha YH, Xiong JQ, et al. : Phytoremediation as a green biotechnology tool for emerging environmental pollution: a step forward towards sustainable rehabilitation of the environment. Chem Eng J. 2021;415: 129040. 10.1016/j.cej.2021.129040 [DOI] [Google Scholar]
  • 75. Rana A, Samtiya M, Dhewa T, et al. : Health benefits of polyphenols: a concise review. J Food Biochem. 2022;46(10): e14264. 10.1111/jfbc.14264 [DOI] [PubMed] [Google Scholar]
  • 76. Galvano F, Piva A, Ritieni A, et al. : Dietary strategies to counteract the effects of mycotoxins: a review. J Food Prot. 2001;64(1):120–131. 10.4315/0362-028x-64.1.120 [DOI] [PubMed] [Google Scholar]
  • 77. Wu JC, Lai CS, Tsai ML, et al. : Chemopreventive effect of natural dietary compounds on xenobiotic-induced toxicity. J Food Drug Anal. 2017;25(1):176–186. 10.1016/j.jfda.2016.10.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Chuang WY, Hsieh YC, Lee TT: The effects of fungal feed additives in animals: a review. Animals (Basel). 2020;10(5):805. 10.3390/ani10050805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Mathuria N, Verma RJ: Aflatoxin induced hemolysis and its amelioration by turmeric extracts and curcumin in vitro. Acta Pol Pharm. 2007;64(2):165–168. [PubMed] [Google Scholar]
  • 80. Saleemi MK, Ashraf K, Gul ST, et al. : Toxicopathological effects of feeding aflatoxins B 1 in broilers and its ameliosration with indigenous mycotoxin binder. Ecotoxicol Environ Saf. 2020;187: 109712. 10.1016/j.ecoenv.2019.109712 [DOI] [PubMed] [Google Scholar]
  • 81. Bhatti SA, Khan MZ, Saleemi MK, et al. : Protective role of bentonite against aflatoxin B 1-and ochratoxin A-induced immunotoxicity in broilers. J Immunotoxicol. 2017;14(1):66–76. 10.1080/1547691X.2016.1264503 [DOI] [PubMed] [Google Scholar]
  • 82. Mitchell NJ, Xue KS, Lin S, et al. : Calcium montmorillonite clay reduces AFB 1 and FB 1 biomarkers in rats exposed to single and co‐exposures of aflatoxin and fumonisin. J Appl Toxicol. 2014;34(7):795–804. 10.1002/jat.2942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Afriyie-Gyawu E, Ankrah NA, Huebner HJ, et al. : NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008;25(1):76–87. 10.1080/02652030701458105 [DOI] [PubMed] [Google Scholar]
  • 84. Lai Y, Sun M, He Y, et al. : Mycotoxins binder supplementation alleviates aflatoxin B 1 toxic effects on the immune response and intestinal barrier function in broilers. Poult Sci. 2021;101(3): 101683. 10.1016/j.psj.2021.101683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Zhao L, Feng Y, Wei JT, et al. : Mitigation effects of bentonite and yeast cell wall binders on AFB 1, DON, and OTA induced changes in laying hen performance, egg quality, and health. Toxins (Basel). 2021;13(2):156. 10.3390/toxins13020156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Chen K, Fang J, Peng X, et al. : Effect of selenium supplementation on aflatoxin B 1-induced histopathological lesions and apoptosis in bursa of Fabricius in broilers. Food Chem Toxicol. 2014;74:91–97. 10.1016/j.fct.2014.09.003 [DOI] [PubMed] [Google Scholar]
  • 87. Liang N, Wang F, Peng X, et al. : Effect of sodium selenite on pathological changes and renal functions in broilers fed a diet containing aflatoxin B 1. Int J Environ Res Public Health. 2015;12(9):11196–11208. 10.3390/ijerph120911196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Singh H, Sodhi S, Kaur R: Effects of dietary supplements of selenium, vitamin E or combinations of the two on antibody responses of broilers. Br Poult Sci. 2006;47(6):714–719. 10.1080/00071660601040079 [DOI] [PubMed] [Google Scholar]
  • 89. Chand N, Muhammad D, Durrani FR, et al. : Protective effects of milk thistle ( Silybum marianum) against aflatoxin B 1 in broiler chicks. Asian-Aust J Anim Sci. 2011;24(7):1011–1018. 10.5713/ajas.2011.10418 [DOI] [Google Scholar]
  • 90. Singh C, Prakash C, Mishra P, et al. : Hepatoprotective efficacy of Premna integrifolia L. leaves against aflatoxin B 1-induced toxicity in mice. Toxicon. 2019;166:88–100. 10.1016/j.toxicon.2019.05.014 [DOI] [PubMed] [Google Scholar]
  • 91. Makhuvele R, Matshoga RG, Antonissen R, et al. : Genotoxicity and antigenotoxicity of selected South African indigenous plants. S Afr J Bot. 2018;114:89–99. 10.1016/j.sajb.2017.10.016 [DOI] [Google Scholar]
  • 92. Makhuvele R, Foubert K, Hermans N, et al. : Protective effects of methanolic leaf extracts of Monanthotaxis caffra against aflatoxin B 1-induced hepatotoxicity in rats. Onderstepoort J Vet Res. 2022;89(1):e1–e6. 10.4102/ojvr.v89i1.1968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Pauletto M, Giantin M, Tolosi R, et al. : Discovering the protective effects of resveratrol on aflatoxin B 1-induced toxicity: a whole transcriptomic study in a bovine hepatocyte cell line. Antioxidants (Basel). 2021;10(8):1225. 10.3390/antiox10081225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Liu Y, Wu F: Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118(6):818–824. 10.1289/ehp.0901388 [DOI] [PMC free article] [PubMed] [Google Scholar]
Open Res Afr. 2025 Mar 6. doi: 10.21956/openresafrica.16864.r32135

Reviewer response for version 2

Samir Abbès 1

The paper entitled Immunomodulatory effects of aflatoxin B1 (AFB1) and the use of natural products to ameliorate its immunotoxic effects: A review, is well written and very informative but the following suggestions should be addressed.

  • In the abstract section, Many other products and extracts from plants are used against Aflatoxine’s immunotoxicity like Radish,….Jebali et al (2015 1), Abbès et al (2016 2), Ben Salah-Abbès et al (2015 3). (please add information for the readers, both in abstract and introduction section, and plant extract section).

  • Keywords section: The review discuss also the amelioration of the AFB1 immunotoxicities, its preferable to add in the keywords ….prevention/ameliorate… 

  • Add a section for AFB1 regulation and risk assessment and discuss it with the used dose causing immunotoxicities.

  • Add table with AFB1 doses and immune target organs to give more information to the readers.

Is the review written in accessible language?

Yes

Are all factual statements correct and adequately supported by citations?

Yes

Are the conclusions drawn appropriate in the context of the current research literature?

Yes

Is the topic of the review discussed comprehensively in the context of the current literature?

Yes

Reviewer Expertise:

Immunotoxicity of mycotoxins

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

References

  • 1. : Ability of Lactobacillus plantarum MON03 to mitigate aflatoxins (B1 and M1) immunotoxicities in mice. J Immunotoxicol .2015;12(3) : 10.3109/1547691X.2014.973622 290-9 10.3109/1547691X.2014.973622 [DOI] [PubMed] [Google Scholar]
  • 2. : Interaction of aflatoxin B1 and fumonisin B1 in mice causes immunotoxicity and oxidative stress: Possible protective role using lactic acid bacteria. J Immunotoxicol .2016;13(1) : 10.3109/1547691X.2014.997905 46-54 10.3109/1547691X.2014.997905 [DOI] [PubMed] [Google Scholar]
  • 3. : Immuno-physiological alterations from AFB1 in rats counteracted by treatments with Lactobacillus paracasei BEJ01 and montmorillonite clay mixture. J Immunotoxicol .2016;13(5) : 10.3109/1547691X.2016.1145157 628-37 10.3109/1547691X.2016.1145157 [DOI] [PubMed] [Google Scholar]
Open Res Afr. 2024 Nov 22. doi: 10.21956/openresafrica.15564.r30532

Reviewer response for version 1

Miklós Mézes 1

Comments:

  • NovaSil Clay is a trademark. Please avoid adding a trademark in a scientific paper. Please specify the clay.

  • Please use the term mold instead of fungus.

  • The statement’ hepatocarcinogen in animal models’ is partly true because the IARC category of AFB1 is Group 1 human carcinogen.

  • Please mention that the hydroxylated metabolite AFM1 is excreted through the milk, and this way would be important in aflatoxicosis in young mammals and infants.

  • Figure 1: Please modify that AFB1 is produced by other Aspergillus species, e.g., A. parasiticus and others. For this reason, it would be better to use the term, e.g ., A. flavus

  • Please mention in the manuscript that the effect of AFB1 on the production traits and lower body weight of farm animals is a consequence of the worse utilization of feed proteins.

  • Restructuring the subchapter “Use of natural products to alleviate immunotoxic effects of aflatoxin B1” requires. For instance, medicinal herbs, clays, and others (e.g., selenium). Its present form is a mix of products with different modes of action. This subchapter must mention which products are binders and which act within the metabolism in different organs.

Is the review written in accessible language?

Yes

Are all factual statements correct and adequately supported by citations?

Partly

Are the conclusions drawn appropriate in the context of the current research literature?

Yes

Is the topic of the review discussed comprehensively in the context of the current literature?

Yes

Reviewer Expertise:

Mycotoxin research with particular interest of oxidative stress

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Open Res Afr. 2025 Jan 7.
Gilbert Kipkoech 1

Thank you for your comments. I have addressed them accordingly.

Open Res Afr. 2024 Feb 24. doi: 10.21956/openresafrica.15564.r30705

Reviewer response for version 1

Francis Padi Lamptey 1

This review summarized the interaction between AFB 1 and the host immune system. It highlights other potential mechanisms involved in AFB1-induced immunosuppression. It discusses findings on natural products that have been found capable of inhibiting AFB1-induced immunosuppression in some animal models. This is an interesting and good work done. However, I think the authors should pay attention to the following:

1. Aflatoxin B1 or any type of Aflatoxin should be written as subscript; say, B 1, B 2, G 1, G 2, etc.

2. Remove the statement recent findings or explain why you are saying recent findings when you clearly stated in your methodology that age was not considered when choosing articles to write this paper.

3. Reference 95 should be taken into the work. It is not very appropriate to include a reference in the conclusion.

4. The sub-heading methodology has systematic review. This should be taken out since this is not a systematic review. For more information on systematic review, read on, PRISMA in systematic review.

5. Saleemi et al. (2020) does not have a superscript to show that it is a reference. Kindly do it well.

Is the review written in accessible language?

Yes

Are all factual statements correct and adequately supported by citations?

Yes

Are the conclusions drawn appropriate in the context of the current research literature?

Yes

Is the topic of the review discussed comprehensively in the context of the current literature?

Yes

Reviewer Expertise:

Mycotoxins, Non-Destructive Measurement, Food Fraud, Food Quality and Food Safety.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Open Res Afr. 2025 Jan 7.
Gilbert Kipkoech 1

Than you for your comments.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Availability Statement

    No data are associated with this article.


    Articles from Open Research Africa are provided here courtesy of African Academy of Sciences

    RESOURCES